Biocon Biologics Inc. et al. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2024-00298
Filing Date Dec 18, 2023
Institution Decision Date Jan 31, 2024
Decision Date Jul 23, 2024
Court Patent Trial and Appeal Board
Status Terminated-Adverse Judgment
Administrative JudgesRyan H. Flax, Susan L. C. Mitchell, Robert A. Pollock
Judge Writing the Final DecisionRyan H. Flax
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
Claims Invalidated: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
Petitioner
Patent Owner
Petitioner Attorneys
6Biocon Biologics Limited
Attorney Name: Neil B. McLaughlin
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Steven J. Birkos
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Thomas H. Ehrich
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Jeffrey A. Marx
Rakoczy Molino Mazzochi Siwik
Biocon Biologics Limited
Attorney Name: Deanne M. Mazzochi
Rakoczy Molino Mazzochi Siwik
Patent Owner Attorneys
3Regeneron Pharmaceuticals
Attorney Name: Adam R. Brausa
Morrison & Foerster
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11253572 | Use of a VEGF antagonist to treat angiogenic eye disorders | Feb 22, 2022 |
